AVAH Stock — Aveanna Healthcare Holdings, Inc.

Up next

Next earnings call

Dec 3, 2026 Est · unconfirmed · in 9 wks

Latest filing: 10-Q

filed Aug 13, 2026

Q2 2027 earnings call transcript

call held Aug 13, 2026

Metrics snapshot

Useful current figures from the complete screener profile.

View all 115 metrics

Revenue (TTM)

$2.60B

Trailing 12 months

Net income (TTM)

$274.76M

Trailing 12 months

Revenue growth YoY

+13.7%

Year over year

Operating margin

10.5%

Trailing 12 months

P / E (TTM)

10.1

Trailing earnings · reciprocal yield 9.9%

FCF yield

—

TTM · current market cap

Return on invested capital

—

Trailing 12 months

Net cash

−$1.20B

Latest balance sheet

Dividend yield

—

Trailing 12 months

Shares change YoY

+6.9%

Year over year · more shares

Price change (1Y)

+44.1%

Trailing year

Short interest

2.5%

Latest settlement · 1.9 days to cover

View all 115 metrics

Equibles Rating

blended score · not investment advice

Overall

Neutral

SellHoldBuy

Technical Neutral Momentum Strong Sentiment Neutral Fundamentals Excellent Quant / Vol Very High

Market backdrop VIX 16.3 · calm Equity put/call 0.53

Technical

price trend

Neutral

50 / 200-day cross No cross

Price vs 200-day avg +41%

above

Price vs 50-day avg +3%

above

RSI (14) 42

neutral

MACD trend Negative

52-week position 76%

mid-range

Volume (OBV) Confirms

volume backs price

Momentum

relative strength

Strong

1-month return −8%

trailing

6-month return +88%

trailing

YTD return +52%

this year

Relative strength +76%

vs S&P · 6-mo

Sentiment

smart money

Neutral

Trend (MA cross) No cross

50d $12 › 200d $9 — 50d above 200d

Institutional flow Accumulating

+9% holders QoQ · +54 funds added

Insider flow Distributing

Net -$558.5M over 90 days · 100% sells

Short interest Rising

2.52% of float · ▲ +0.3% MoM · 1.9 days cover

Volume signal Reversal watch

High volume on a down day — possible exhaustion

Institution breadth Multi-yr high

216 holders — near 3-yr high, broad support

Squeeze score 54

elevated · 0–100

Fundamentals

Excellent

Revenue growth +20%

Y/Y

Gross margin 33%

expanding

EPS growth +1850%

Y/Y

Free cash flow $109.9M

Valuation P/E 10

below peers

Balance sheet $1.1B

net debt

Quant / Vol

risk profile

Very High

Volatility 50%

annualized · 1-yr

Max drawdown −39%

past year

ATR 4.2%

of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Guidance & track record

what management promised — and delivered

Beat or met 2 of last 4

Latest guidance · from the 8-K filed Aug 13, 2026

Revenue · full fiscal year 2026 (year ending January 2, 2027) at least $2.68B

prior FY $2.43B midpoint +10.1% Y/Y

Adjusted EBITDA · full fiscal year 2026 (year ending January 2, 2027) Non-GAAP at least $365M

Guided vs delivered · last 4 settled

Revenue full year 2024

guided at least $1.99B

guided at least $1.99B $2.02B In line

Revenue full year 2023

guided $1.87B – $1.88B

guided $1.87B – $1.88B $1.9B Beat +1.1%

Revenues full year 2022

guided $1.89B – $1.92B

guided $1.89B – $1.92B $1.79B Miss −6.2%

Revenue full year 2021

guided at least $1.75B

guided at least $1.75B $1.68B Miss −3.8%

Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

Technicals

trend & momentum for long-term holders Neutral

1 · 4 · 2

50 / 200-day cross

No cross Neutral

Price vs 200-day avg

+41% Bullish

Price vs 50-day avg

+3% Bullish

RSI (14)

42 Neutral

MACD trend

Negative Bearish

52-week position

76% Neutral

Volume (OBV)

Confirms Neutral

Market signals — smart money & positioning

Mixed

Trend (MA cross) No cross

50d $12 › 200d $9 — 50d above 200d

Institutional flow Accumulating

+9% holders QoQ · +54 funds added

Insider flow Distributing

Net -$558.5M over 90 days · 100% sells

Short interest Rising

2.52% of float · ▲ +0.3% MoM · 1.9 days cover

Volume signal Reversal watch

High volume on a down day — possible exhaustion

Institution breadth Multi-yr high

216 holders — near 3-yr high, broad support

Price context

position in its 52-week range

Range low $6 Now $12 · 76% Range high $14

vs 200-day avg +41% vs 50-day avg +3%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

the company's own KPIs, from written earnings releases and filings

Metric	Latest	Period	YoY
Adjusted EBITDA non-GAAP	$179.8M	Six-Month Periods Ended July 4, 2026	—

Adjusted net income per diluted share non-GAAP	$0.4	Six-Month Periods Ended July 4, 2026	—

Cost of revenue rate	$31.9	Six-month period ended July 4, 2026	—
Cost of revenue rate (MS)	$274.46	Q2 FY2026	—
Field contribution non-GAAP	$231.08M	Six-month period ended July 4, 2026	—
Field contribution margin	17.5%	six-month period ended July 4, 2026	—
Free cash flow non-GAAP	$75.4M	Six-Month Periods Ended July 4, 2026	—
Home health episodic admissions	17.4K	Six-month period ended July 4, 2026	—
Home health episodic mix	80.9%	Six-month period ended July 4, 2026	—
Home health revenue per completed episode	$3,185	Six-month period ended July 4, 2026	—
Home health total admissions	21.5K	Six-month period ended July 4, 2026	—
Home health total episodes	29.6K	Six-month period ended July 4, 2026	—
Hours	24.47M	Six-month period ended July 4, 2026	—
Revenue rate	$44.53	Six-month period ended July 4, 2026	—
Revenue rate (MS)	$500.33	Q2 FY2026	—
Spread rate	$12.63	Six-month period ended July 4, 2026	—
Spread rate (MS)	$225.87	Q2 FY2026	—
Unique patients served ("UPS")	188K	six-month period ended July 4, 2026	—

Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

Versus peers

Medical Care Facilities — same industry group

Open screener →

Company	Mkt cap	YTD	Rev growth Y/Y	P/E	Short % shares
AVAH Aveanna Healthcare Holdings, Inc. this stock	$2.75B	+51.9%	+20.2%	10.0	2.5%
HCA HCA Healthcare, Inc.	$96.64B	-8.6%	+7.1%	15.0	2.9%
FSNUY Fresenius SE & Co. KGaA	$29.92B	-11.6%	—	—	0.0%
THC Tenet Healthcare Corp	$20.91B	+28.6%	+0.9%	10.0	2.5%
EHC Encompass Health Corp	$12.18B	+14.5%	+10.5%	20.1	3.0%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section

Ownership

Institutional Holders Accumulating

Holders

216

% held: 92.6%
Net QoQ: +4.1M sh
Top holder: Bain Capital Investors LLC

Held Float

View

Held by Funds

Fund positions

226

View

Short & Settlement

Short Interest Rising

Shares short

5.5M

Days to cover: 1.9d
Change: +17.8K sh

View

Short Volume

Short vol %

27%

As of: Sep 30, 2026

Short Total

View

Fails to Deliver

FTD shares

125

Value: $1.7K
As of: Sep 11, 2026

View

Off-Exchange

Off-exchange %

38.1%

Week of: Aug 24, 2026

Off-exch Lit

View

Smart Money

Insider Trades Net selling

Net (90d)

-$558.5M

Buyers / Sellers: 0 / 6

Buyers Sellers

View

Financials

Revenue (FY)

$2.4B

Net income (FY): $225.0M
EPS diluted: $1.05

View

Filings

SEC Filings

Latest

Investor Event Transcript

Filed: Sep 16, 2026
This year: 21

View

Proposed Sales

Value

$645.0K

Shares: 46.1K
Filed: Sep 9, 2026

View

Earnings & Events

Earnings Calls

Last call

Sep 16, 2026

View

Investor Relations

	5D	20D	120D	MTD	YTD
AVAH	-3.0%	-7.8%	+87.8%	-7.5%	+51.9%
SPY	-0.7%	+0.1%	+12.2%	-0.6%	+11.8%
vs SPY	-2.3%	-7.9%	+75.6%	-7.0%	+40.1%

AVAH · Aveanna Healthcare Holdings, Inc.

Price & Indicators

Up next

Metrics snapshot

Equibles Rating

Guidance & track record

Technicals

Key metrics

Versus peers

At a glance

Performance